関連する概念動画
01:24Chronic Obstructive Pulmonary Disease
2.8K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:20COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Mepolizumab Efficacy in COPD: Insights from Longitudinal Patterns of Blood Eosinophil Counts and Their Variability Across Three Clinical Trials.
American journal of respiratory and critical care medicine·2026
Same author
Development of an artificial intelligence prediction model for moderate-to-severe COPD exacerbations using continuous multiple unobtrusive sensors: protocol of a multicentre prospective observational study.
BMJ open respiratory research·2026
Same author
A randomised controlled trial of EP395, a novel anti-inflammatory macrolide, in stable COPD patients.
ERJ open research·2026
Same author
The construct validity of real-world digital mobility outcomes in people with COPD.
ERJ open research·2026
Same author
Small airways disease is common in mild COPD and symptomatic subjects at risk with normal spirometry: baseline data from CAPTO-COPD.
ERJ open research·2026
Same author
Clinically relevant change in airway wall thickness to identify disease activity in COPD and smokers at risk.
The European respiratory journal·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026
慢性閉塞性肺疾患
1LungenClinic Grosshansdorf, Airway Research Centre North, German Centre for Lung Research, Grosshansdorf, Germany; Department of Medicine, Christian Albrechts University Kiel, Kiel, Germany.
Lancet (London, England)
|May 18, 2017
まとめ
慢性閉塞性肺疾患 (COPD) は 世界的に大きな健康問題であり 毎年300万人以上が死亡しています 治療における進歩は限られており,タバコの使用と環境への曝露を減らすためのより良い理解と世界的な努力の必要性を強調しています.
科学分野:
- 肺医学
- 公衆衛生
- 流行病学について
背景:
- 慢性閉塞性肺疾患 (COPD) は,毎年300万人以上の死亡率で,死亡率の主な原因です.
- 現在の治療法は主に症状を管理し,悪化を予防し,疾患の進行や生存に限られた影響を及ぼします.
- COPDの発達に伴う複雑なメカニズムの理解には大きなギャップがあります.
研究 の 目的:
- COPDの病原性をより深く理解する必要性を強調する.
- COPDの世界的な負担を減らすための重要な戦略を強調する.
- 総合的な公衆衛生と政策の介入を提唱する.
主な方法:
- COPDのメカニズム,治療,予防に関する現在の文献のレビュー.
- COPDに関連する世界的な死亡率と罹患率のデータ分析
- 喫煙,環境への曝露,バイオマス燃料の使用がCOPDに与える影響の評価
主要な成果:
- 治療の進歩にもかかわらず,COPDの進行と死亡率はほとんど影響を受けていません.
- 禁煙,身体活動,併発症の管理は,COPDの影響を軽減するために不可欠です.
- タバコの使用と環境リスクを抑えるには,世界的な政治的,経済的行動が不可欠です.
結論:
- COPDの複雑なメカニズムを全面的に理解することは 効果的な介入策の開発に不可欠です
- 禁煙,環境規制,代替燃料などの統合戦略が必要である.
- COPDは根源的な原因に対処する 協調的な世界的な努力がなければ 医療における大きな課題として 存在し続けるでしょう